Bonita David P
SEC CIK 1572451 · EDGAR
BoughtSold
Most active insiders at PRLD, 12 months
| # | Insider | Title | Bought | Sold |
|---|---|---|---|---|
| 1 | Bonita David P | Dir, 10% | $12.50M | — |
| 2 | ORBIMED ADVISORS LLC | Dir, 10% | $12.50M | — |
| 3 | Huang Jane | Pres, CMO | — | — |
| 4 | RA CAPITAL MANAGEMENT, L.P. | 10% | — | — |
Transactions 9
| X | Filed | Traded | Ticker | Company | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| MI | 2026-04-23 18:50 | 2026-04-21 | PRLD | Prelude Therapeutics Inc | Bonita David P | Dir, 10% | P - Purchase | $4.44 | +2.82M | 1.13M | New | +$12.50M |
| D | 2025-07-30 | 2025-07-25 | IMA | ImageneBio, Inc. | Bonita David P | Dir | M - OptEx | — | +379 | 379 | New | — |
| DI | 2025-07-30 | 2025-07-25 | IMA | ImageneBio, Inc. | Bonita David P | Dir | P - Purchase | $29.90 | +83.6K | 287.9K | +41% | +$2.50M |
| DAI | 2023-09-21 | 2023-08-04 | IMA | ImageneBio, Inc. | Bonita David P | Dir | A - Grant | — | +153.1K | 5.58M | +3% | — |
| DI | 2023-09-14 | 2023-08-04 | IMA | ImageneBio, Inc. | Bonita David P | Dir | A - Grant | — | +153.1K | 2.25M | +7% | — |
| I | 2023-05-24 | 2023-05-22 | PRLD | Prelude Therapeutics Inc | Bonita David P | Dir, 10% | P - Purchase | $5.75 | +869.6K | 10.12M | +9% | +$5.00M |
| MI | 2022-06-24 | 2022-06-22+ | IMA | ImageneBio, Inc. | Bonita David P | Dir | P - Purchase | $4.47 | -252.2K | 2.10M | -11% | -$1.13M |
| AI | 2021-07-23 | 2021-07-16 | ELVN | Enliven Therapeutics, Inc. | Bonita David P | Dir, 10% | P - Purchase | $6.00 | +1.67M | 4.20M | +66% | +$10.00M |
| I | 2021-07-16 | 2021-07-16 | ELVN | Enliven Therapeutics, Inc. | Bonita David P | Dir, 10% | P - Purchase | $6.00 | +1.67M | 1.67M | New | +$10.00M |
Purchase Sale Sale after option exercise All abbreviations